Research on Cervical Cancer and Its Drug Treatment

Abstract

Cervical cancer is one of the common malignant tumors in gynecology, usually due to persistent infection with human papillomavirus (HPV). At present, the main therapeutic drugs used in clinical practice are traditional chemotherapeutic drugs and targeted drugs, and drug therapy mainly includes traditional cytotoxic chemotherapy, targeted therapy, immunotherapy. Because traditional chemotherapeutic drugs usually can not solve the problem of drug resistance and side effects, people started using molecular biology and genomics study of targeted drug therapy. This article mainly discusses the target drug treatment of cervical cancer, anti-angiogenesis, immune checkpoint inhibitor treatment methods, as they have been applied in the treatment of cervical cancer and showed effect, which also brought new hope for the treatment of cervical cancer.